Barings’s Chemed CHE Stock Holding History

Barings’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,200	Closed	-$330K	–	942
2015 Q4	$330K	Hold	2,200	–	–	0.01%	748
2015 Q3	$294K	Buy	+2,200	New	+$308K	0.01%	764
2014 Q2	–	Sell	-65,685	Closed	-$5.88M	–	968
2014 Q1	$5.88M	Sell	65,685 -42,315	-39%	-$3.45M	0.18%	109
2013 Q4	$8.28M	Buy	108,000 +1,300	+1%	+$95.8K	0.35%	57
2013 Q3	$7.63M	Buy	106,700 +80,500	+307%	+$5.73M	0.33%	62
2013 Q2	$1.9M	Buy	+26,200	New	+$1.92M	0.09%	253

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Barings's CHE Position: Q1 2016 in Review

Barings sold out of Chemed (CHE) in Q1 2016, closing a stake of 2,200 shares — an estimated $330K sold.

Barings first reported a position in CHE in Q2 2013 and held it in 6 quarters. The position peaked at $8.28M in Q4 2013. 236 funds tracked by Wall St. Rank hold CHE as of Q1 2016.

Barings reported no remaining Chemed position as of Q1 2016 after selling out during the quarter.
Barings sold 2,200 Chemed shares in Q1 2016, an estimated $330K.
Barings first reported a position in Chemed in Q2 2013 and held it in 6 quarters.
Barings's Chemed position peaked at $8.28M in Q4 2013.
236 funds tracked by Wall St. Rank held Chemed as of Q1 2016.

Based on Barings's 13F filing for Q1 2016, filed 16 May 2016.